A Phase I Trial of Oral Ridaforolimus (AP23573; MK-8669) in Combination with Bevacizumab for Patients with Advanced CancersJohn Nemunaitis, Monica Mita, Howard S. Höchster et al.|Clinical Oncology|2013Cited by 13